These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10856546)
1. Effect of immunosuppressive therapy on DNA repair and cancer incidence in renal transplant recipients. Weinstein T; Korzets A; Chagnac A; Ori Y; Herman M; Zevin D; Malachi T; Gafter U Transplant Proc; 2000 Jun; 32(4):694-5. PubMed ID: 10856546 [No Abstract] [Full Text] [Related]
6. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone. Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543 [No Abstract] [Full Text] [Related]
7. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine. Fabrega AJ; Corwin CL; Hunsicker L Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634 [No Abstract] [Full Text] [Related]
10. Long-term results and risk factors of quadruple immunosuppression in renal transplantation. Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496 [No Abstract] [Full Text] [Related]
11. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression. Tsai MK; Lee PH; Hu RH; Lee CJ Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381 [No Abstract] [Full Text] [Related]